Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives. Aktas O, Albrecht P, Hartung H-P Curr Opin Neurol. 2016 Mar 31. PMID: 27035900. Abstract CommentRecommendBookmarkWatch